0001493152-21-009398.txt : 20210421 0001493152-21-009398.hdr.sgml : 20210421 20210421175511 ACCESSION NUMBER: 0001493152-21-009398 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210416 FILED AS OF DATE: 20210421 DATE AS OF CHANGE: 20210421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreiber Christopher C CENTRAL INDEX KEY: 0001750076 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 21842644 MAIL ADDRESS: STREET 1: AKERS BIOSCIENCES, INC. STREET 2: 201 GROVE ROAD CITY: THOROFARE STATE: NJ ZIP: 08086 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4 1 ownership.xml X0306 4 2021-04-16 0 0001321834 MyMD Pharmaceuticals, Inc. MYMD 0001750076 Schreiber Christopher C 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK, NY 10036 1 0 0 0 Common Stock 2021-04-16 4 M 0 131750 A 134351 D Common Stock 2021-04-16 4 F 0 46113 4.94 D 88238 D Restricted Stock Units 2021-04-16 4 M 0 131750 0.00 D Common Stock 131750 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company"). Represents 46,113 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 131,750 shares of RSUs on April 16, 2021. On September 11, 2020, the reporting person was granted 131,750 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control. /s/ Christopher C. Schreiber 2021-04-21